Merus NV held an extraordinary general meeting of shareholders on December 9, 2025. Shareholders approved the proposals related to the back-end transactions under the transaction agreement with Genmab, including the statutory merger with Merus Merger B.V. The appointment of Greg Mueller, Anthony Pagano, and Martine van Vugt, Ph.D. as non-executive directors was also approved. Another proposal referenced a Dutch tax ruling, which was obtained prior to the meeting and therefore rendered the proposal moot.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merus NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-312721), on December 09, 2025, and is solely responsible for the information contained therein.
Comments